Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Graham

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2001
Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosisP Sadaphal, J Astemborski, N M Graham, et al.
Annals of Internal Medicine|July 15, 1994
The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort StudyD S Stein, N M Graham, L P Park, et al.
American Journal of Epidemiology|December 1, 1992
Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivityM Concha, N M Graham, A Muñoz, et al.
Lancet (London, England)|August 3, 1991
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort StudyN M Graham, S L Zeger, L P Park, et al.
JAMA|October 7, 1997
Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope. Identification by DNA fingerprintingT M Michele, W A Cronin, N M Graham, et al.
The New England Journal of Medicine|January 9, 1986
Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family settingR M Douglas, B W Moore, H B Miles, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
Virologic, immunologic, and immune activation markers as predictors of HIV-associated weight loss prior to AIDS. Multicenter AIDS Cohort StudyR H Lyles, A M Tang, E Smit, et al.
Annals of Internal Medicine|June 15, 1996
Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study GroupN M Graham, D R Hoover, L P Park, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2001
Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohortS L Becker, S R Raffanti, N I Hansen, et al.
The Journal of Infectious Diseases|April 7, 1999
Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposureM Kimura, P J Converse, J Astemborski, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2001
Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosisP Sadaphal, J Astemborski, N M Graham, et al.
Annals of Internal Medicine|July 15, 1994
The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort StudyD S Stein, N M Graham, L P Park, et al.
American Journal of Epidemiology|December 1, 1992
Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivityM Concha, N M Graham, A Muñoz, et al.
Lancet (London, England)|August 3, 1991
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort StudyN M Graham, S L Zeger, L P Park, et al.
JAMA|October 7, 1997
Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope. Identification by DNA fingerprintingT M Michele, W A Cronin, N M Graham, et al.
The New England Journal of Medicine|January 9, 1986
Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family settingR M Douglas, B W Moore, H B Miles, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
Virologic, immunologic, and immune activation markers as predictors of HIV-associated weight loss prior to AIDS. Multicenter AIDS Cohort StudyR H Lyles, A M Tang, E Smit, et al.
Annals of Internal Medicine|June 15, 1996
Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study GroupN M Graham, D R Hoover, L P Park, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2001
Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohortS L Becker, S R Raffanti, N I Hansen, et al.
The Journal of Infectious Diseases|April 7, 1999
Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposureM Kimura, P J Converse, J Astemborski, et al.
Pageof 11